Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype

References

• Suerbaum S, Michetti P. Helicobacter pylori infection. N. Engl. J. Med.347, 1175–1186 (2002).
   PubMed Web of Science ®Google Scholar
• Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer2, 28–37 (2002).
   PubMed Web of Science ®Google Scholar
• Parsonnet J. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther.9(Suppl. 2), 45–51 (1995).
   PubMedGoogle Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55, 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentaion, treatment, and prevention. Med. Clin. North Am.89, 313–344 (2005).
   PubMed Web of Science ®Google Scholar
• Graham DY. Helicobacter pylori infection is the primary cause of gastric cancer. J. Gastroenterol.35(Suppl. 12), 90–97 (2000).
   PubMedGoogle Scholar
• Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl Acad. Sci. USA90(12), 5791–5795 (1993).
   PubMed Web of Science ®Google Scholar
• Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl Acad. Sci. USA102(45), 16339–16344 (2005).
   PubMed Web of Science ®Google Scholar
• Svennerholm A-M, Lundgren A. Progess in vaccine development against Helicobacter pylori. FEMS Immunol. Med. Microbiol.50, 146–156 (2007).
   PubMedGoogle Scholar
• Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev.19, 449–490 (2006).
   PubMed Web of Science ®Google Scholar
• Algood HM, Cover TL. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin. Microbiol. Rev.19, 597–613 (2006).
   PubMedGoogle Scholar
• Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ gene-deficient mice. J. Immunol.165, 1022–1029(2000).
   PubMed Web of Science ®Google Scholar
• Vorobjova T, Nilsson I, Kull K et al. CagA protein seropositivity in a random sample of adult population and gastric cancer patients in Estonia. Eur. J. Gastroenterol. Hepatol.10(1), 41–46 (1998).
   PubMedGoogle Scholar
• Said Essa A, Alaa Eldeen Nouh M, Mohammed Ghaniam N, Graham DY, Said Sabry H. Prevalence of cagA in relation to clinical presentation of Helicobacter pylori infection in Egypt. Scand. J. Infect. Dis.40(9), 730–733 (2008).
   PubMed Web of Science ®Google Scholar
• Palli D, Masala G, Del Giudice G et al. CagA+Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int. J. Cancer120(4), 859–867 (2007).
   PubMed Web of Science ®Google Scholar
• Beales IL, Crabtree JE, Scunes D, Covacci A, Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol.8(7), 645–649 (1996).
   PubMed Web of Science ®Google Scholar
• O’Keeffe Moran AP. Conventional, regulatory, and unconventional T cells in the immunologic response to Helicobacter pylori. Helicobacter13, 1–19 (2008).
   PubMedGoogle Scholar
• Scalzo K, Plebanski M, Apostolopoulos V. Regulatory T-cells: immunomodulators in health and disease. Curr. Top. Med. Chem.6, 1759–1768 (2006).
   PubMedGoogle Scholar
• Mills KH. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol.4, 841–855 (2004).
   PubMed Web of Science ®Google Scholar
• Enarsson K, Lundgren A, Kindlund B et al. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma. Clin. Immunol.121, 358–368 (2006).
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res.52, 673–675 (1992).
   Google Scholar
• Haber MM. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol. Clin. North Am.31, 395–419 (2002).
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S et al.Helicobacter pylori and the development of gastric cancer. N. Engl. J. Med.345, 784–789 (2001).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Uyterlinde AM, Pena AS et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet345, 1525–1528 (1995).
   PubMed Web of Science ®Google Scholar
• Annibale B, Negrini R, Caruana P et al. Two thirds of patients with atrophic body gastritis have evidence of Helicobacter pylori infection. Helicobacter6, 225–233 (2001).
   PubMed Web of Science ®Google Scholar
• Tatsuta M, Iishi H, Nakaizumi A et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int. J. Cancer53, 70–74 (1993).
   PubMed Web of Science ®Google Scholar
• Wu M-S, Chen C-J, Lin J-T. Host–environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol. Biomarkers Prev.14, 1878–1882 (2005).
   PubMed Web of Science ®Google Scholar
• De Vries AC, van Grieken NC, Looman CW et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology134(4), 945–952 (2008).
   PubMed Web of Science ®Google Scholar
• Vannella L, Lahner E, Bordi C et al. Prevalence, incidence and risk factors for gastric neoplastic lesions in patients with atrophic body gastritis. Digest. Liv. Dis. (41), S116–S117 (2009).
   Google Scholar
• Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic pattern of intestinal metaplasia and gastric cancer. Am. J. Gastroenterol.95, 1431–1438 (2000).
   PubMed Web of Science ®Google Scholar
• Annibale B, Lahner E. Assessing the severity of atrophic gastritis. Eur. J. Gastroenterol. Hepatol.19, 1059–1063 (2007).
   PubMedGoogle Scholar
• Lahner E, Bordi C, Cattaruzza MS et al. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment. Pharmacol. Ther.22, 471–481 (2005).
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum. Pathol.36, 228–233 (2005).
   PubMed Web of Science ®Google Scholar
• Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract. Res. Clin. Gastroenterol.15, 983–998 (2001).
   PubMed Web of Science ®Google Scholar
• Hansson L-E, Nyren O, Hsing AW et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Eng. J. Med.335, 242–249 (1996).
   PubMed Web of Science ®Google Scholar
• El-Omar ME, Oien K, Murray LS et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of Helicobacter pylori. Gastroenterology118, 22–30 (2000).
   PubMed Web of Science ®Google Scholar
• Eisenbrand G, Adam B, Peter M, Malfertheiner P, Schlag P. Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate: a possible risk factor for gastric carcinogenesis. IARC Sci. Publ.57, 963–968 (1984).
   Google Scholar
• Annibale B, Capurso G, Lahner E et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut52, 496–501 (2003).
   PubMed Web of Science ®Google Scholar
• Beales IP, Calam J. Interleukin 1b and tumour necrosis factor a inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut42, 227–234 (1998).
   PubMed Web of Science ®Google Scholar
• Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-a, interleukin-1b, and interleukin-8 production in patients with Helicobacter pylori infection. Scand. J. Gastroenterol.29, 425–429 (1994).
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology110, 1744–1752 (1996).
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Carringtom M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature404, 398–402 (2000).
   PubMed Web of Science ®Google Scholar
• Rad R, Prinz C, Neu B et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis.188, 272–281 (2003).
   PubMed Web of Science ®Google Scholar
• Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1b polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology123, 92–105 (2002).
   PubMed Web of Science ®Google Scholar
• Camargo MC, Mera R, Correa P et al. Interleukin-1b and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev.15, 1674–1687 (2006).
   PubMed Web of Science ®Google Scholar
• Lahner E, Corleto VD, D’Ambra G, Di Giulio E, Delle Fave G, Annibale B. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis? Aliment. Pharmacol. Ther.27, 355–365 (2008).
   PubMedGoogle Scholar
• Ferlay J, Bray F, Pisani P et al. GLOBOCAN 2002. In: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base no. 5 version 2.0, IARC Press, Lyon, France (2004).
   Google Scholar
• Hundahl SA, Menck HR, Mansour EG, Winchester DP. The National Cancer Data Base report on gastric carcinoma. Cancer..80, 2333–2341 (1997).
   PubMed Web of Science ®Google Scholar
• Wong BC, Lam SK, Wong WM et al.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA291, 187–194 (2004).
   PubMed Web of Science ®Google Scholar
• Del Giudice G, Malfertheiner P, Rappuoli R. Development of vaccines against Helicobacter pylori. Expert Rev. Vaccines8(8), 1037–1049 (2009).
   PubMed Web of Science ®Google Scholar
• Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter12, 89–102 (2007).
   PubMed Web of Science ®Google Scholar
• Rugge M. Secondary prevention of gastric cancer. Gut56, 1646–1647 (2007).
   PubMedGoogle Scholar
• Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol.20, 1161–1181 (1996).
   PubMed Web of Science ®Google Scholar
• Rugge M, Cassaro M, Pennelli G et al. Atrophic gastritis: pathology and endoscopy in the reversibility assessment. Gut52(9), 1387–1388 (2003).
   PubMedGoogle Scholar
• Väänänen H, Vauhkone M, Helske T et al. Nonendoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur. J. Gastroenterol. Hepatol.15, 885–891 (2003).
   PubMed Web of Science ®Google Scholar
• Derakhshan MH, El-Omar E, Oien K et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J. Clin. Pathol.59(12), 1293–1299 (2006).
   PubMedGoogle Scholar
• Di Mario F, Cavallaro LG, Moussa AM et al. Usefulness of serum pepsinogens in Helicobacter pylori chronic gastritis: relationship with inflammation, activity, and density of the bacterium. Dig. Dis. Sci.51(10), 1791–1795 (2006).
   PubMed Web of Science ®Google Scholar
• Graham DY, Nurgalieva ZZ, El-Zimaity HM et al. Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America. Clin. Gastroenterol. Hepatol.4(3), 306–314 (2006).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur. J. Gastroenterol. Hepatol.15(8), 877–879 (2003).
   PubMedGoogle Scholar
• Nardone G, Rocco A, Staibano S et al. Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment. Pharmacol. Ther.22(11–12), 1139–1146 (2005).
   PubMedGoogle Scholar
• Pasechnikov VD, Chukov SZ, Kotelevets SM et al. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study. Scand. J. Gastroenterol.40(3), 297–301 (2005).
   PubMed Web of Science ®Google Scholar
• Ricci C, Vakil N, Rugge M et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am. J. Gastroenterol.99(10), 1910–1915 (2004).
   PubMedGoogle Scholar
• Blaser MJ, Crabtree JE. CagA and the outcome of Helicobacter pylori infection. Am. J. Clin. Pathol.106, 565–567 (1996).
   PubMed Web of Science ®Google Scholar
• Annibale B, Lahner E, Santucci A et al. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter12, 23–30 (2007).
   PubMed Web of Science ®Google Scholar
• Ekström AM, Held M, Hansson L-E, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology121, 784–791(2001).
   PubMed Web of Science ®Google Scholar
• Mini R, Annibale B, Lahner E, Bernardini G, Figura N, Santucci A. Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin. Chem.52, 220–226 (2006).
   PubMed Web of Science ®Google Scholar
• Linz B, Balloux F, Moodley Y et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature445(7130), 915–918 (2007).
   PubMed Web of Science ®Google Scholar
• Gao L, Michel A, Weck MN, Arndt V, Pawlita M, Brenner H. Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res.69(15), 6164–6170 (2009).
   PubMedGoogle Scholar
• Klade CS. Proteomics approaches towards antigen discovery and vaccine development. Curr. Opin. Mol. Ther.4(3), 216–223 (2002).
   PubMed Web of Science ®Google Scholar
• Bernardini G, Braconi D, Lusini P, Santucci A. Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev. Proteomics4(5), 679–689 (2007).
   PubMed Web of Science ®Google Scholar
• Sanchez-Campillo M, Bini L, Comanducci M et al. Identification of immunoreactive proteins of Chlamydia trachomatis by western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis20(11), 2269–2279 (1999).
   PubMed Web of Science ®Google Scholar
• Jungblut PR, Grabher G, Stöffler G. Comprehensive detection of immunorelevant Borrelia garinii antigens by two-dimensional electrophoresis. Electrophoresis20(18), 3611–3622 (1999).
   PubMed Web of Science ®Google Scholar
• Nowalk AJ, Gilmore RD Jr, Carroll JA et al. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun.74(7), 3864–3873 (2006).
   PubMed Web of Science ®Google Scholar
• Vytvytska O, Nagy E, Blüggel M et al. Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics2(5), 580–590 (2002).
   PubMed Web of Science ®Google Scholar
• Ariel N, Zvi A, Makarova KS et al. Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect. Immun.71(8), 4563–4579 (2003).
   PubMed Web of Science ®Google Scholar
• Jungblut PR. Proteome analysis of bacterial pathogens. Microbes. Infect.3(10), 831–840 (2001).
   PubMed Web of Science ®Google Scholar
• Kimmel B, Bosserhoff A, Frank R, Gross R, Goebel W, Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect. Immun.68, 915–920 (2000).
   PubMed Web of Science ®Google Scholar
• Krah A, Miehlke S, Pleissner KP et al. Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int. J. Cancer108, 456–463 (2004).
   PubMed Web of Science ®Google Scholar
• Jungblut PR, Bumann D, Haas G et al. Comparative proteome analysis of Helicobacter pylori. Mol. Microbiol.36(3), 710–725 (2000).
   PubMed Web of Science ®Google Scholar
• Haas G, Karaali G, Ebermayer K et al. Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics2, 313–324 (2002).
   PubMed Web of Science ®Google Scholar
• Mini R, Bernardini G, Salzano AM et al. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.833, 63–79 (2006).
   PubMed Web of Science ®Google Scholar
• Lin YF, Wu MS, Chang CC et al. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol. Cell. Proteomics5, 1484–1496 (2006).
   PubMed Web of Science ®Google Scholar
• McAtee CP, Lim MY, Fung K et al. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin. Diagn. Lab. Immunol.5(4), 537–542 (1998).
   PubMedGoogle Scholar
• Lin YF, Chen CY, Tsai MH et al. Duodenal ulcer-related antigens from Helicobacter pylori: immunoproteome and protein microarray approaches. Mol. Cell. Proteomics6(6), 1018–1026 (2007).
   PubMedGoogle Scholar
• Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics164(4), 1567–1587 (2003).
   PubMed Web of Science ®Google Scholar
• Lahner E, Santucci A, Bernardini G et al. Immunoproteomics of Helicobacter pylori allows to identify patients with gastritis a high risk for gastric cancer. Gut56(Suppl. III), A104 (2007).
   Google Scholar
• Forman D, Pisani P. Gastric cancer in Japan – honing treatment, seeking causes. N. Engl. J. Med.359(5), 448–451 (2008).
   PubMedGoogle Scholar
• Hunt JD, Mera R, Strimas A et al.KRAS mutations are not predictive for progression of preneoplastic gastric lesions. Cancer Epidemiol. Biomarkers Prev.10(1), 79–80 (2001).
   PubMedGoogle Scholar
• Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science284(5418), 1328–1333 (1999).
   PubMed Web of Science ®Google Scholar
• Hynes SO, McGuire J, Wadström T. Potential for proteomic profiling of Helicobacter pylori and other Helicobacter spp. using a ProteinChip array. FEMS Immunol. Med. Microbiol.36(3), 151–158 (2003).
   PubMed Web of Science ®Google Scholar